Reported 2 days ago
Eli Lilly and Company (NYSE: LLY) is emerging as a leading dividend growth stock in the pharmaceutical sector, boasting an impressive annual payout increase of 16% over the past five years. With a strong presence in the expanding weight loss market and a promising pipeline of potential blockbuster drugs, Eli Lilly's revenues and earnings outpace many competitors, positioning it well for sustained dividends and long-term investor gains. Recently, the company declared a quarterly dividend of $1.50 per share, marking 11 consecutive years of payout growth.
Source: YAHOO